Clinical Trials in Chiba-ken, Japan
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 1
Study of INCB123667 in Subjects With Advanced Solid Tumors
Solid Tumors
Incyte Corporation604 enrolled42 locationsNCT05238922
Recruiting
Phase 1
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Myeloproliferative Neoplasms
Incyte Corporation225 enrolled29 locationsNCT05936359